Contact
Please use this form to send email to PR contact of this press release:
Hudson Therapeutics and Shaperon Explore Licensing Opportunities for Oral Atopic Dermatitis Treatment for Pets
TO:
Ellie Jung
Hudson Therapeutics, Inc, US Subsidiary of Shaperon